Healthcare Corporate Finance News
 Market Intelligence on Health Care Venture Capital, M&A, Private Equity, and IPOs

Home | Publications | Resource Center | Database | Free Trials | Conference | Order | Senior Care Blog | Search | Contact Us 1-800-248-1668
 

We will not sell or trade your email--ever.    Privacy Policy

2003 Index

Back issues are available in electronic version (PDF).

Please Call
:
800-248-1668
203-846-6800

Click here for the pdf version of this index.

Healthcare Corporate Finance News
(formerly: Jenks Healthcare Business Report)

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Symbols
3i Mar p. 7
3M Apr p. 16

A
Abbott Laboratories Jan p. 7, Feb p. 5, Mar p. 7, Apr p. 6, Aug p. 12, Sep p. 12, Dec p. 8
Abgenix Jun p. 3
Abingworth Management Aug p. 8, Sep p. 7
ABN AMRO Capital, Cross Atlantic Partners May p. 6
Accelerator Jun p. 7
Accredo Health Feb p. 3
Accusphere Nov p. 3
Achillion Pharmaceuticals, Inc. Jul p. 4
Aclara Biosciences Apr p. 4
Acorda Therapeutics May p. 6, Oct p. 3
Acusphere, Inc. Jul p. 3, Oct p. 3
Adams, Harkness & Hill May p. 6
Aderis Pharmaceuticals Sep p. 4, Oct p. 3, Nov p. 3
Advance PCS Oct p. 16
Advanced Cell Technology Apr p. 6
Advanced Healthcare Technologies Feb p. 5
Advanced Life Sciences Oct p. 13
Advanced Technology Fund Jun p. 7
AdvancePCS Apr p. 16, Sep p. 4
Advancis Pharmaceutical Corp. Jun p. 3, Jul p. 3, Nov p. 3, Aug p. 4, Oct p. 3
Aetna Feb p. 2, Mar p. 12, May p. 4, Jun p. 12, Sep p. 12, Dec p. 12
Affymetrix, Inc. Feb p. 3, Dec p. 4
Agassi Enterprises Apr p. 16
AIDS Healthcare Foundation Feb p. 12
Alaska Science & Technology Foundation Jul p. 16
Alcon, Inc. Jan p. 5
Allergan Jul p. 16
Allou Healthcare May p. 6
Alnylam Holding Co. Jul p. 10
Alnylam Pharmaceuticals Inc. Jul p. 10
Alta Partners Apr p. 3, May p. 7, Aug p. 7
Altea Therapeutics Jan p. 10
Alterra Healthcare Corp. Apr p. 4, Aug p. 2
Alvardo Hospital Medical Center Aug p. 12
Amarin Corp. Feb p. 5
AMB-Amro Jun p. 7
Ambrx Inc. Oct p. 14
American Family Care, Inc. Jul p. 2
American Federation of State Apr p. 16
American Medical Laboratories Feb p. 5
Amerigroup Jul p. 1
AMERIGROUP Corporation Nov p. 6
Amersham plc Oct p. 6
Amgen Jan p. 10, Feb p. 3, Jul p. 5
Amsurg Apr p. 2
AnalgesiX Jul p. 10
Andrx Corp. Mar p. 12
Angiotech Pharmaceuticals, Inc. Oct p. 3
Antex Biologics Mar p. 4, Apr p. 4
Anthem Feb p. 2, Mar p. 12, Nov p. 1, Dec p. 12
Antigenics Feb p. 5
Apax Partners Feb p. 6
Apollo Real Estate Funds Jan p. 3
Applied Molecular Evolution Dec p. 8
ARCH Venture Partners Jun p. 7, Oct p. 13
Ardent Health Services Dec p. 8
Arrow Therapeutics Oct p. 13
ARV Assisted Living Jan p. 3
AstraZeneca Aug p. 7
AtheroGenics Feb p. 4
Atlas Venture Jun p. 7
Atria Senior Quarters Jan p. 3
Auriga Partners Feb p. 6
Aventis Behring Dec p. 8
Aventis Pasteur Apr p. 16
Aventis, SA Dec p. 8

B
Bacchus Vascular Inc. Jul p. 7
Banc of America Securities Jan p. 5, Jun p. 1, Jul p. 1, Nov p. 6
Bank One Corporation Aug p. 3
Banyu Pharmaceutical Jan p. 2
Battelle Memorial Institute Mar p. 7
BattellePharma Mar p. 7
Bausch & Lomb Mar p. 4
Baxter International Mar p. 3
Bay City Capital Fund III Oct p. 10
Bayer AG Jan p. 16, Mar p. 12, Sep p. 8
Bayer Corp. May p. 12
Baystar Capital Apr p. 4
Baystar Capital Management Oct p. 10
Bear Stearns Health Innoventures Jan p. 10
Beckman Coulter Oct p. 16, Dec p. 12
Benchmark Capital Jan p. 13
Biofrontier Partners Apr p. 13
Biogen, Inc. Mar p. 12, Aug p. 1, Jul p. 7
Biolipox Feb p. 6
BioMarin Pharmaceutical Mar p. 3
BioMarker Pharmaceuticals May p. 12
BioMedicines Inc. Sep p. 7
Biomira Jul p. 5
Bioport Corp. Mar p. 4
BioPort Corporation Apr p. 4
BioScience Managers Limited May p. 7
Biosite Feb p. 3
Biotechnology Industry Organization Jan p. 6
BioTransplant Inc. Apr p. 4
Birchwood Capital Advisors Feb p. 5
Blue Cross and Blue Shield Association Nov p. 2
Blue Cross and Blue Shield of Texas Jul p. 2
Blue Cross Blue Shield Dec p. 12
Boehringer Ingelheim Sep p. 7
Boston Scientific Corp. Jul p. 16, Oct p. 1
Brazos Private Equity Jan p. 10
Bristol-Myers Squibb Jan p. 16, Feb p. 12, Mar p. 1, May p. 12, Jun p. 2, Jul p. 5, Dec p. 3
British Columbia Cancer Agency May p. 12
Broadlane Inc. Jul p. 10
Burrill & Co. Sep p. 7

C
Cadwalader, Wickersham & Taft Apr p. 16
CalPERS Jan p. 13
Cambridge Antibody Technologies Jan p. 10
Canadian Pension Plan Investment Board Jan p. 14
CancerVax Corp. Aug p. 8, Sep p. 4, Oct p. 3, Nov p. 4
Capital Senior Living Dec p. 4
Cardinal Health Mar p. 1
Care Capital Aug p. 8
CareFirst Jun p. 5
Caremark Rx Apr p. 16, Sep p. 4, Oct p. 16
Caxton Corp. Apr p. 10
CDIB BioScience Ventures Aug p. 7
CellGate Aug p. 8
Celltech Group PLC Jul p. 5
Cellzome Apr p. 10
Celsion Corp. Aug p. 12
Cendant Apr p. 1
Centene Corp. Jul p. 1
Center for Disease Control May p. 12
Centerpulse AG Apr p. 6, Aug p. 2
Centerre Healthcare Corp. Jan p. 10 & 15, Feb p. 10, Apr p. 14, May p. 10, Jun p. 10, Jul p. 14, Aug p. 11, Sep p. 11, Oct p. 14, Nov p. 11
Cephalon, Inc. Jun p. 5
CG Nutritionals Aug p. 12
Children’s Hospital Boston Mar p. 7
China Development Industrial Bank Jan p. 10
Chiron Corp. Feb p. 3, Apr p. 3, Jun p. 5
Christus Health Dec p. 8
Chugai Pharmaceutical Co. Jan p. 2
CIBC World Markets Jan p. 5, Jul p. 1, Dec p. 3
Cigna Corp. Jan p. 16, Feb p. 2, Jun p. 12
Citigroup Oct p. 3
Citigroup Global Markets May p. 6
CLSA Private Equity Jan p. 13
CNL Retirement Properties Jan p. 3
Cobalt Corp. Jun p. 5
Cohesive Technologies Jul p. 10
Colson & Colson/Holiday Retirement Jan p. 2
Combimatrix May p. 12
Computer Motion, Inc. Apr p. 10
Coniston Partners Apr p. 10
Conmed Corp. Nov p. 12
Connecticut Innovations Jul p. 16
Control Delivery Systems Mar p. 3
Cooper Hill Partners Oct p. 13
Corautus Genetics Inc. Feb p. 5
Cordis Corp. Oct p. 1
CoreRatings Apr p. 6
Corgentech Inc. Dec p. 3
Corixa Corp. Jul p. 5
Corus Pharma Mar p. 5
County and Municipal Employees Apr p. 16
Credit Lyonnais Private Equity Feb p. 6
Credit Suisse First Boston Nov p. 4, Dec p. 3
Critical Home Care Jan p. 16
CryoCor Inc. Jun p. 10
CSFB Private Equity May p. 7
CSL Limited Dec p. 8
Curative Health Services Oct p. 16, Nov p. 12
Curis Jul p. 5
Cytodyne Technologies Jul p. 16
Cytokinetics Inc. May p. 7

D
Danaher Corp. Dec p. 8
Dealogic Jun p. 5
DeCODE Genetics Oct p. 13
Deloitte & Touche Mar p. 7
Deltagen Apr p. 4
Dentsply International Dec p. 8
DePuy AcroMed May p. 6
Deutsche Bank Securities Nov p. 4
Digene Corp. Apr p. 4
Disetronic Holding AG Feb p. 9
Diversified Biotech Holdings Inc. Aug p. 6
Domain Apr p. 4
Domain Associates Jan p. 10, Apr p. 13, Jun p. 7, Jul p. 7
Dov Pharmaceuticals Jan p. 5
drugstore.com Feb p. 12
Duke University Jan p. 10
Duquesne Capital Apr p. 10

E
Easton Hunt Capital Partners May p. 6, Aug p. 7
Eclipse Clinical Technologies Oct p. 13
Edison Venture Fund Aug p. 8
Edwards Lifesciences Corp. May p. 6, Oct p. 2
EGS Healthcare Capital Partners Apr p. 13
Elan Corp. Feb p. 3, Apr p. 16, Jul p. 7, Sep p. 4, Nov p. 6
Eli Lilly & Co. Jan p. 16, Feb p. 5, Mar p. 12, Jun p. 12, Jul p. 5, Dec p. 8
Elixir Pharmaceuticals Feb p. 5, Feb p. 10
Emeritus Assisted Living Aug p. 2
Endius Apr p. 13
Endo Pharmaceuticals Holdings Jul p. 4
Enron Jan p. 13
Entremed Jun p. 3
Enzon Pharmaceuticals Mar p. 7
Ernst & Young Apr p. 2, Jun p. 7
Ernst & Young/Venture One May p. 6
ESP Pharma Inc. May p. 10
Esperion Therapeutics Jul p. 5
Essex Woodlands Health Ventures Jan p. 10, Mar p. 4
Eterna Technologies Apr p. 4
Ethicon Endo-Surgery Inc. Aug p. 3
Eunoe, Inc. Jul p. 7
ExcelleRx Mar p. 5
Exelixis, Inc. Jul p. 5
Express Scripts Apr p. 16, Oct p. 16
Eyetech Sep p. 4

F
Fidelity Management & Research Sep p. 1
First Genetic Trust Oct p. 13
First Health Services Corp. Jun p. 12
Fisher Scientific International Jul p. 7
Flagship Ventures Jun p. 7, Aug p. 7
Flavin Ventures, LLC Oct p. 13
Flextronics USA Inc. Oct p. 16, Dec p. 12
Forest Laboratories Jul p. 5
Forward Ventures Apr p. 3, Jul p. 10
Frazier Healthcare Ventures Jun p. 7
Fulbright & Jaworsky Sep p. 12

G
Galen Holdings Mar p. 9
GE Medical Systems Oct p. 6
Genentech Feb p. 3, Jun p. 1, Jul p. 5, Jul p. 7, Aug p. 8, Sep p. 7, Dec p. 12
General American Investors May p. 7
General Electric Company Jan p. 1, Oct p. 6
General Motors Investment Management Jul p. 10
Genesis Health Ventures Apr p. 4
GeneTrax Feb p. 12
Genitope Corp. Aug p. 4, Nov p. 4, Dec p. 3
Genzyme Corp. Mar p. 5, Dec p. 4
Geron Corporation Nov p. 6
GE’s Life Science and Technology Finance Group Jan p. 10
GlaxoSmithKline Jan p. 16, Feb p. 12, Mar p. 7, Mar p. 12, Apr p. 6, May p. 7, Aug p. 4
Global Alliance for Vaccines and Immunisation Feb p. 12
Goldman Sachs Mar p. 2, Jul p. 5, Oct p. 10
GSK May p. 7
Guidant Corporation Jan p. 1, Oct p. 2
Guilford Pharmaceuticals Dec p. 7

H
HBM BioVentures May p. 7, Aug p. 7
HBO & Co. Jun p. 12
HCA Inc. Jan p. 16, Jul p. 16
Health Management Associates Sep p. 5, Dec p. 10
Health Net Sep p. 12
HealthCap Feb p. 6, Aug p. 7, Nov p. 7
Healthcare Ventures Jul p. 10, Aug p. 8
HealtheTech, Inc. Jan p. 5, Apr p. 16, Oct p. 5
HealthPoint LLC Mar p. 7
HealthSouth Corp. Jan p. 3, Apr p. 1, Jun p. 12, Jul p. 15, Aug p. 12, Sep p. 12, Oct p. 16, Nov p. 12, Dec p. 12
Hoechst Marion Roussel Jun p. 7
Humana Mar p. 12, Sep p. 12
Hypnion, Inc. Apr p. 10 & 14

I
I-many, Inc. Dec p. 9
i-STAT Dec p. 8
IADF Venture Capital Jan p. 13
ICC Venture Capital Oct p. 13
ICN Pharmaceuticals Apr p. 16, Jul p. 15, Aug p. 2
ICOS Corp. Jan p. 6
ID Biomedical Corporation Oct p. 3, Nov p. 6
Idec Pharmaceuticals Jul p. 7, Aug p. 1
Idenix Pharmaceuticals Apr p. 6
Igen International Aug p. 3
ImClone Systems Jan p. 5, Mar p. 1, Apr p. 6, Jun p. 2, Aug p. 12
Immunicon Corp. Dec p. 3
IMPAC Medical Systems May p. 6, Sep p. 4
Imperial College London May p. 7
IMS Health Jan p. 7
Inspire Pharmaceuticals Mar p. 3
Instrumentarium Corp. Jan p. 1, Oct p. 10
Intersouth Partners Mar p. 7
InterWest Partners Jun p. 7, Nov p. 4
InTouch Health Apr p. 10, Jul p. 10
IntraBiotics Pharmaceuticals Feb p. 3, Oct p. 5
Intrinsic Therapeutics Feb p. 6
Invemed Catalyst Fund, L.P. Oct p. 10
Invesco Private Capital Apr p. 13
InvestBio Inc. Aug p. 6
InvestPrivate, Inc. Aug p. 6
Invus Group Aug p. 7
Iomai Corp. Jan p. 10
Ivax Mar p. 12

J
J.P. Morgan Partners Dec p. 3
Janssen Pharmaceuticals Nov p. 12
Johnson & Johnson Jan p. 1, Feb p. 6, Apr p. 6, May p. 6, Jul p. 16, Aug p. 2, Oct p. 1, Nov p. 12
JP Morgan Oct p. 10
JP Morgan Fleming Asset Management May p. 6
JP Morgan Partners Jan p. 10, Nov p. 4
JP Morgan Securities Nov p. 4

K
Kaiser Permanente Jul p. 10
Kentucky Association of Health Care Plans Apr p. 16
Kindred Healthcare Feb p. 12, Jul p. 10
Kinexis Aug p. 6
King Pharmaceuticals Feb p. 9, Apr p. 16
Kirin Brewery Jan p. 16

L
Laboratory Corp. of America Apr p. 5
Lazard Freres Jan p. 3
Lehman Brothers Jan p. 5, Aug p. 4, Nov p. 3, Dec p. 3
Lincare Holdings Inc. Jun p. 5
Link Spine Group, Inc. May p. 6
LivHOME Mar p. 10
Logistics Health Inc. Dec p. 7
Lombard Odier Darier Hentsch & Cie Jan p. 13
Lorus Therapeutics Inc. Jul p. 5

M
Macquarie Capital Partners May p. 6
Magellan Health Services Inc. Jun p. 7
MagnaCare Feb p. 6
Marriott International Jan p. 2
Marriott Senior Living Services Jan p. 2
Marshall Edwards Oct p. 3
Martek Biosciences Apr p. 4, May p. 6
Mathys Medical Aug p. 4
Mayfield Fund May p. 7
Mayne Group Ltd. May p. 12
McKesson Corp. Mar p. 1, Jun p. 12
MDS Capital Apr p. 4, Jun p. 7, Aug p. 7
Medco Health Solutions Mar p. 3, Apr p. 10, Aug p. 7, Oct p. 16, Nov p. 12, Dec p. 12
Medex, Inc. Aug p. 3
Medical Alley Apr p. 13
MediChem Life Sciences Oct p. 13
MedImmune Ventures Jan p. 10, Jul p. 5, Aug p. 8
Medinet Co. Dec p. 3
Medpartners Sep p. 4
MedSource Technologies Jan p. 5, Feb p. 3
Medtronic Feb p. 9, Aug p. 2, Oct p. 2
MedUnite Jan p. 3
Merck Jan p. 2, Feb p. 1, Mar p. 3, Apr p. 10, Jul p. 5, Aug p. 7, Sep p. 2, Oct p. 16, Nov p. 12, Dec p. 12
Merck KGaA Apr p. 6, Jun p. 2
Merck-Medco Jan p. 5
Merrill Lynch Mar p. 7, Oct p. 3
Metage Capital Sep p. 8
Mid Atlantic Medical Services Nov p. 1
Milliman USA Nov p. 1
MitoKor Apr p. 3
Mizuho Capital May p. 7
Molina Healthcare, Inc. Jan p. 5, Jul p. 1, Sep p. 4, Nov p. 3
Morgan Stanley Oct p. 10, Nov p. 4
MPM Apr p. 10
MPM Bioventures III Feb p. 5
MPM Capital Jan p. 13, Jun p. 7, Aug p. 8, Nov p. 7
Mylan Labs Mar p. 12
Myogen Sep p. 4, Nov p. 4

N
National Home Health Care Corp. Nov p. 12
National Medical Enterprises Nov p. 12, Dec p. 12
National Surgical Care Jan p. 10
National Venture Capital Assn. May p. 7
Nationwide Health Properties Apr p. 4
Needham & Company May p. 6
Neoforma Inc. Dec p. 9
Neurochem Inc. Oct p. 2
NeuroMed Technologies Nov p. 7
New Enterprise Associates Jan p. 10, Feb p. 6, Aug p. 8, Sep p. 7, Nov p. 4
NitroMed, Inc. Sep p. 4, Nov p. 4
Nobex Sep p. 7
Novartis AG Apr p. 6, Jul p. 5
Novation Dec p. 10
Noven Pharmaceutical Mar p. 9
NPS Pharmaceuticals Mar p. 7

O
Omnicare Jun p. 5
OncoTherapy Science Dec p. 3
One Equity Partners Aug p. 3
Onex Corp. Jun p. 7
Oppen-heimer & Co. Oct p. 5
Option Care Oct p. 16
OrbiMed Advisors Jun p. 7
Orchid BioSciences Apr p. 4
Organon Jul p. 5
Orion Mar p. 12
Orqis Medical Corp. Jul p. 7
Ortho Biotech Jul p. 16
Oxford Bioscience Apr p. 10
Oxford Health Plans Feb p. 1, Apr p. 4, Dec p. 12
Oxigene Jun p. 3

P
PA Early Stage Partners III Mar p. 7
Pacific Equities Aug p. 4
Pain Therapeutics Oct p. 3
Pall Corp. Feb p. 3
Pan Pharmaceuticals Ltd. May p. 12
Parke-Davis/Warner-Lambert Jun p. 7
Pediatrix Medical Group Jul p. 16, Dec p. 12
Peptimmune, Inc. Mar p. 5
Perbio Science AB Jul p. 7
Perlegen Sciences Feb p. 6
Perseus Soros BioPharmaceutical Fund Feb p. 5
Pfizer Jan p. 1, Mar p. 7, Apr p. 3, Apr p. 6, May p. 12, Jul p. 5, Sep p. 1, Oct p. 16, Nov p. 12, Dec p. 8
Pharmaceutical Care Management Association Sep p. 12
Pharmacia Corp. Jan p. 1, Jan p. 16, Mar p. 7, Mar p. 9, Apr p. 10, Sep p. 1, Dec p. 8
Pharmion Corporation Jul p. 4, Sep p. 4, Nov p. 4, Dec p. 3
Pointilliste Aug p. 6
Polaris Venture Jun p. 7
PowderJect Pharmaceuticals Jun p. 5
PPL Therapeutics plc Sep p. 8
Prescription City Nov p. 12
Prism Venture Jun p. 7
PRM Ventures May p. 7
Prometheus Assisted Living, LLC Jan p. 3
ProQuest Investments Jan p. 10
Prospect Venture Partners Aug p. 8
Providence Service Corporation Jul p. 3, Aug p. 4, Sep p. 3, Nov p. 3
Province Healthcare Dec p. 8
ProxyMed Jan p. 3
Putnam Investments Mar p. 2, Sep p. 1

Q
QLT Inc. Mar p. 12
Quaker BioVentures Mar p. 7
QuatRx Pharmaceuticals Jun p. 7
Quest Diagnostics Feb p. 5, Apr p. 5
Quintiles Transnational Corp. Aug p. 3, Oct p. 13

R
Radiometer A/S Dec p. 8
Radius Ventures Mar p. 7
Raven Biotechnologies Jan p. 10
Regenecor Holdings Sep p. 8
Regenecor Inc. of Virginia Sep p. 8
Reliant Pharmaceuticals LLC Oct p. 10, Dec p. 7
Renovis Aug p. 7
Restoragen Jan p. 16
Restore Medical Feb p. 12
Rho Ventures Aug p. 8
Rib-X Pharmaceuticals May p. 7
Ribapharm Apr p. 16, Jun p. 12, Aug p. 2
Ribopharma AG Jul p. 10 & 15
Ribozyme Pharmaceuticals Feb p. 5, Jul p. 10
Rinat Neuroscience Corp. Sep p. 7
Roan/Meyers & Associates Mar p. 4
Roche Holding AG Jan p. 2, Feb p. 9, Mar p. 12, Apr p. 6, Jul p. 5, Aug p. 3, Sep p. 2
Ross Products Aug p. 12
Royal Philips Electronics Jul p. 7
RW Baird Mar p. 7

S
Sankyo Apr p. 13
Sankyo Pharma Inc. Jun p. 7
Santarus Inc. Jun p. 7
Scheer & Co. Mar p. 7
Schering AG Sep p. 7
Schering-Plough Jan p. 10, Mar p. 2, May p. 4, Jun p. 12, Sep p. 1, Dec p. 10
Schroder Ventures Jun p. 7
Schroder Ventures International Life Sciences III Feb p. 5
Scios, Inc. Feb p. 6
SDS Capital Partners Apr p. 4
Senior Home Care Mar p. 10
Sepracor Dec p. 4
Sequoia Capital Sep p. 12
Sevin Rosen May p. 7
SG Asset Management Apr p. 13
SG Cowen Jan p. 5, Jul p. 1, Oct p. 3
Shionogi BioResearch Apr p. 10
Shire Pharmaceuticals Group Mar p. 9
Sierra Health Services Sep p. 12
Singapore’s BioMedical Sciences Investment Fund Jan p. 10
Sirna Therapeutics Jul p. 10
Skyline Ventures Jan p. 10, Aug p. 7
Smith & Nephew Apr p. 6, Aug p. 2
Soffinova Partners Feb p. 6
Songbird Hearing Inc. Jan p. 15, Nov p. 11
Sopherion Therapeutics Mar p. 7
Spray Venture Fund Feb p. 6
Sprout Group Feb p. 6, Aug p. 8
St. Paul Venture Capital Jun p. 7
Standard & Poor Aug p. 7
Stryker Corp. Apr p. 6, Aug p. 2
Summerville Senior Living Jan p. 3
Sunrise Assisted Living Jan p. 2, May p. 6
SunTrust Robinson Humphrey Jul p. 3
Symbion May p. 5
Synergia Pharma Feb p. 5
Synovis Life Technologies Oct p. 5
Synta Pharmaceuticals Apr p. 10
Synthes-Stratec Aug p. 4
Synthetech, Inc. Apr p. 4

T
TA Associates Dec p. 7
Targeted Genetics Jun p. 5
Techno Venture Management May p. 6, Nov p. 7
Technology Partners Jun p. 7
Technology Venture Partners Feb p. 12
Tel Aviv University May p. 7
Teleflex Inc. Mar p. 5
Tenet Healthcare Corp. Jan p. 3, Feb p. 2, Jun p. 12, Jul p. 10, Aug p. 12, Sep p. 5, Nov p. 12, Dec p. 12
Tenet Healthsystem Hospitals Inc. Aug p. 12
Tercica, Inc. Aug p. 7, Sep p. 4
Teva Pharmaceutical Industries Mar p. 12
The Bill & Melinda Gates Foundation Feb p. 12
The Biocapital Fund Jul p. 10
The Carlyle Group Apr p. 13
The Congress of California Seniors Jan p. 16
The Cook Group Jan p. 1
The Indiana Future Fund Nov p. 8
The Institute for Systems Biology Jun p. 7
Therion Bio-logics Corp. Sep p. 7
Thomas, McNerney & Partners May p. 7
Thomas Weisel Partners LLC May p. 6, Apr p. 13, Jun p. 7
Three Arch Partners Sep p. 12
TL Ventures Jun p. 7
TolerRx, Inc. Jan p. 10, Sep p. 4, Dec p. 3
Trellis Bioscience Aug p. 6
Triad Hospitals Sep p. 5
Trigon Healthcare Feb p. 2
Trimeris Mar p. 12
Trust Co. of the West Apr p. 10
Tunstall Financial Group Mar p. 5

U
U.S. Bancorp Piper Jaffray Dec p. 3
U.S. Oncology Dec p. 10
UBS Investment Bank Nov p. 6, Dec p. 3
UBS Securities Oct p. 3
Ultreia Capital Ltd. Jan p. 13
United BioSource Corp. Dec p. 7
United Health Care Mar p. 12
United Surgical Partners Apr p. 2
UnitedHealth Group Feb p. 1, Nov p. 1
Universal Health Services Dec p. 8
University Health System Dec p. 10
University of California Sep p. 12
University of Michigan Sep p. 12
University of Rochester Nov p. 12
US Oncology Jul p. 10
UTIMCO Jan p. 13

V
V.I. Technologies Feb p. 3
Valhalla Partners Aug p. 8
Vascular Access Aug p. 3
Venrock Associates Aug p. 7, Oct p. 13, Nov p. 7
Ventas Feb p. 12
Venture Investment Management Co. Oct p. 13
Versant Ventures Jun p. 7
Versitech Ltd. May p. 12
VHA Inc. Dec p. 10
Viasys Mar p. 7
VIMAC Milestone Medica Fund Oct p. 13
Vinson & Elkins Apr p. 16
Vion Pharmaceuticals Jun p. 3
Viragen Sep p. 12
ViroPharma Mar p. 7
VistaCare Jan p. 5
Vital Signs Inc. May p. 12
VitaLife Fund Jun p. 7
Vivus Inc. Nov p. 12
Vulcan Ventures May p. 7
Vysis Inc. Feb p. 5

W
Warburg Pincus May p. 7, Jul p. 7
Warner Lambert Mar p. 12
Watson Pharmaceuticals Jul p. 5
WebMD Corp. Apr p. 3, May p. 5, Sep p. 12, Oct p. 16
WellChoice Inc. Jan p. 5, Apr p. 10, May p. 12
WellPoint Health Networks Feb p. 2, May p. 3, Jun p. 5, Nov p. 1
Wisconsin United for Health Foundation Jun p. 5
Worldcom Jan p. 13
WR Hambrecht & Co. Nov p. 4
Wright Medical Group Aug p. 2
Wyeth Corp. Jan p. 10, Apr p. 3, Dec p. 4

X
Xcel Pharmaceuticals Sep p. 4
Xenogen Corp. Jul p. 14
Xenome Jul p. 10
XOMA Ltd. Oct p. 3

Y
Yahoo Jan p. 6
Yamanouchi Venture Capital Apr p. 13

Z
Z-Medica Aug p. 12
Zimmer Holdings Aug p. 2

Sign up for a trial subscription and get the current issue!

Read more about Healthcare Corporate Finance News (formerly: Jenks Healthcare Business Report).

Back to top

 

 

Irving Levin Associates, Inc.,  268 1/2 Main Avenue, Norwalk, CT 06851
800-248-1668; 203-846-6800
203-846-8300 fax

general@levinassociates.com

Since 1948, Irving Levin Associates, Inc. has been the leading source of information and investment research on mergers and acquisitions in the Behavioral Health Care, Biotech, e-Health, Home Health Care, Hospitals, Laboratories, MRI and Dialysis, Long Term Care, Managed Care, Medical Devices, Pharmaceuticals, Physician Medical Groups, Rehabilitation and other health care markets.

More Irving Levin Information:
Mergers, Acquisitions and Healthcare Venture Capital Financing Research at Irving Levin Associates | Dealmakers Resource Center on Senior Care and Health Care Companies | Healthcare Marketing Research and Healthcare Finance Publications | Database of Healthcare Ventures, Mergers and Acquisitions | Free Trial Request For One Of Our Newsletters Customer Service at Irving Levin Associates | Publication Order Form | Press Room| Contact Us
 

© 1995-2008, Irving Levin Associates, Inc. All rights reserved.